NCT06728917View on ClinicalTrials.gov

Occult Hepatitis B Virus Infection and HBV Reactivation After Switching to Long Acting Therapy in Patients With HIV-1

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

November 30, 2025

Conditions

HBV (Hepatitis B Virus)HIV Infection

Trial Locations (3)

20127

IRCCS San Raffaele O.U. Infectious Diseases, Milan

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

80138

Università Luigi Vanvitelli della Campania, Napoli

All Listed Sponsors

collaborator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

collaborator

Università Luigi Vanvitelli della Campania

UNKNOWN

lead

IRCCS San Raffaele

OTHER

NCT06728917 - Occult Hepatitis B Virus Infection and HBV Reactivation After Switching to Long Acting Therapy in Patients With HIV-1 | Biotech Hunter | Biotech Hunter